Pas­cal So­ri­ot says 2020 ap­proval still pos­si­ble for As­traZeneca's Covid-19 vac­cine as the world awaits the safe­ty board­'s de­ci­sion

Mod­er­na was the first com­pa­ny to put a vac­cine can­di­date in­to hu­mans, but for much of the pan­dem­ic it was As­traZeneca and their aca­d­e­m­ic part­ners …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA